Insider Tracker SEC Form 4 insider trades
← All clusters
PBLS

Parabilis Medicines, Inc.

AI summary Insiders and major shareholders acquire shares in Parabilis Medicines' upsized initial public offering.

40
Insider Score Band below 60
Research score
51
AI adjustment
-11

Research score, not a recommendation.

Total bought$434.5M8 Form 4 purchases
Distinct insiders3open-market buyers
Lead insiderKolchinsky PeterDirector
Cluster window2026-06-11 → 2026-06-15active

Market data

Live quote and chart from Yahoo Finance, loaded through this server. Insider purchases are marked on the chart.

–

partial data Price history is incomplete; missing inputs count as neutral in the score.

Why this score

Research score: a weighted blend of the five factors, times the routine and offering discounts, minus the selling penalty.

Breadth number & diversity of participating insiders
37%
Seniority executive rank of buyers (CEO/CFO/Director)
60%
Commitment purchase size relative to company & holdings
70%
Context buying into stock weakness signals conviction
50%
Timing coordinated purchases within a tight window
99%
Routine-purchase discount × 1.00
Company-type / offering discount × 0.50
Net insider selling penalty − 0

Why are they buying?

AI · ipo_offering · catalyst credible · documented

Insiders and ten percent owners purchased shares directly in connection with the company's initial public offering priced at $20.00 per share, supported by strong investor demand that allowed the company to raise over $700 million in gross proceeds.

Parabilis Medicines completed an upsized initial public offering of 33.5 million shares at $20.00 per share and began trading on the Nasdaq under the symbol PBLS.

Stock Price & Insider Purchase History

Daily close price with open-market insider purchases plotted over time

Loading price history…

Transactions

8 Form 4 trades · 3 insiders Sign in to download CSV
Purchases in this cluster, grouped by insider, largest first
Date Insider Role Shares Price Value Flags Filing
2026-06-11 Kolchinsky Peter history of Kolchinsky Peter's purchases Director 21,188,750 $20.00 avg $423.8M
offering
2026-06-11 Kolchinsky Peter 1,460,397 $20.00 $29.2M
offering
SEC filing for Kolchinsky Peter (opens in a new tab)
2026-06-11 Kolchinsky Peter 19,728,353 $20.00 $394.6M
offering
SEC filing for Kolchinsky Peter (opens in a new tab)
2026-06-11 Soleus Capital, LLC history of Soleus Capital, LLC's purchases 10% owner 500,000 $20.00 avg $10.0M
offering
2026-06-11 Soleus Capital, LLC 125,000 $20.00 $2.5M
offering
SEC filing for Soleus Capital, LLC (opens in a new tab)
2026-06-11 Soleus Capital, LLC 375,000 $20.00 $7.5M
offering
SEC filing for Soleus Capital, LLC (opens in a new tab)
2026-06-11 → 2026-06-15 SEBULSKY ALAN history of SEBULSKY ALAN's purchases Director 30,000 $24.12 avg $723.6K
offering
2026-06-11 SEBULSKY ALAN 12,500 $20.00 $250.0K
offering
SEC filing for SEBULSKY ALAN (opens in a new tab)
2026-06-12 SEBULSKY ALAN 8,435 $27.67 $233.4K
SEC filing for SEBULSKY ALAN (opens in a new tab)
2026-06-15 SEBULSKY ALAN 4,065 $27.10 $110.2K
SEC filing for SEBULSKY ALAN (opens in a new tab)
2026-06-15 SEBULSKY ALAN 5,000 $26.00 $130.0K
SEC filing for SEBULSKY ALAN (opens in a new tab)
Total $434.5M

What happened next

A run ends after a pause in the buying, so one company can have several. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.

After this run became a cluster: 21 days +10.5%63 days +6.0%126 days –